Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus rhamnosus GG and Reduced Urinary Symptom Burden

Doses used in studies

doses/30-hour: 5.6 (median 5.6, IQR 5.6–5.6) — 1 study

Time to effect

Median: 6 months · IQR 6 months–6 months · Range 6 months–6 months — Reported in 1 of 1 study

1 of 1 paper

Effects of Intravesical Lactobacillus Rhamnosus GG on Urinary Symptom Burden in People with Neurogenic Lower Urinary Tract Dysfunction.
- 2020-11-10
- Clinical Trial
- PM & R : the journal of injury, function, and rehabilitation 13(7)
- - Rochelle E Tractenberg
  - Suzanne L Groah
  - Jamie K Frost
  - Amanda K Rounds
  - Elizabeth Davis
  - Inger H Ljungberg
  - Manon M Schladen
- PubMed: 32798286
- DOI: 10.1002/pmrj.12470
1 Insight on
- Reduced Urinary Symptom Burden
- Moderate evidence
- Clinical
For those who instilled at least once, burdens of type A and B2 symptoms were significantly improved at washout (both adjusted P < .05).
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
instilled once or twice in a 30-hour period (5.6 doses on average)